Hi Pivalde, Thank you for reposting this. Maybe with the additional funding now received, DS and the team can set up a primate study similar to the one we did for MSA. Personally, I think DS may shift his focus onto PD before trying to tackle AD. I wonder how it will work given that Professor Masters has been given a license to use ATH434 for further research on AD. It would actually be interesting to find out how far down the track Prof Masters is with his research and what his short-term plans are. I know, Professor Masters is doing his own thing with our molecule, so im not sure how often he updates our management on his progress. One thing is for sure, if we could prove efficacy with PD as well as AD, our Market Cap will well & truly eclipse $15B, in my opinion. They are both massive markets that are completely untapped.
Thanks again for posting, Pivalde. Keep well...
Stockman..
ATH Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)